Role of constitutive androstane receptor in toll-like receptor-mediated regulation of gene expression of hepatic drug-metabolizing enzymes and transporters

Drug Metabolism and Disposition

Volumn 42, Issue 1, 2014, Pages 172-181

  Shah, Pranav ^a   Guo, Tao ^a   Moore, David D ^b   Ghose, Romi ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 BIS(3,5 DICHLORO 2 PYRIDYLOXY)BENZENE; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450 2A4; CYTOCHROME P450 2B10; CYTOCHROME P450 3A11; DRUG METABOLIZING ENZYME; GLUCURONOSYLTRANSFERASE 1A1; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; SULFOTRANSFERASE; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOWN REGULATION; GENE EXPRESSION REGULATION; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL TRANSPORT; CYTOCHROME P-450 ENZYME SYSTEM; DOWN-REGULATION; GENE EXPRESSION; GLUCURONOSYLTRANSFERASE; HEPATOCYTES; LIPOPOLYSACCHARIDES; LIVER; MALE; MEMBRANE TRANSPORT PROTEINS; METABOLIC DETOXICATION, DRUG; MICE; MICE, INBRED C57BL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; TEICHOIC ACIDS; TOLL-LIKE RECEPTORS;

EID: 84890740280     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.113.053850     Document Type: Article

References (34)

1. Aitken AE, Richardson TA, and Morgan ET (2006) Regulation of drug-metabolizing enzymes and transporters in inflammation. Annu Rev Pharmacol Toxicol 46:123-149. (Pubitemid 43271186)
2. Assem M, Schuetz EG, Leggas M, Sun D, Yasuda K, Reid G, Zelcer N, Adachi M, Strom S, and Evans RM, et al. (2004) Interactions between hepatic Mrp4 and Sult2a as revealed by the constitutive androstane receptor and Mrp4 knockout mice. J Biol Chem 279: 22250-22257. (Pubitemid 38679421)
3. Barker CW, Fagan JB, and Pasco DS (1992) Interleukin-1 beta suppresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes. J Biol Chem 267:8050-8055.
4. Baskin-Bey ES, Huang W, Ishimura N, Isomoto H, Bronk SF, Braley K, Craig RW, Moore DD, and Gores GJ (2006) Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins. Hepatology 44:252-262. (Pubitemid 44049157)
5. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, and Feingold KR (2000) The acute phase response is associated with retinoid X receptor repression in rodent liver. J Biol Chem 275: 16390-16399. (Pubitemid 30366957)
6. Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, and Feingold KR (2002) Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem Biophys Res Commun 293:145-149. (Pubitemid 34694183)
7. Cheng PY, Morgan ET (2001) Hepatic cytochrome P450 regulation in disease states. Curr Drug Metab 2:165-183. (Pubitemid 32544553)
8. Durand SH, Flacher V, Roméas A, Carrouel F, Colomb E, Vincent C, Magloire H, Couble ML, Bleicher F, and Staquet MJ, et al. (2006) Lipoteichoic acid increases TLR and functional chemokine expression while reducing dentin formation in in vitro differentiated human odontoblasts. J Immunol 176:2880-2887.
9. Ghose R, Guo T, and Haque N (2009) Regulation of gene expression of hepatic drug metabolizing enzymes and transporters by the Toll-like receptor 2 ligand, lipoteichoic acid. Arch Biochem Biophys 481:123-130.
10. Ghose R, Guo T, Vallejo JG, and Gandhi A (2011) Differential role of Toll-interleukin 1 receptor domain-containing adaptor protein in Toll-like receptor 2-mediated regulation of gene expression of hepatic cytokines and drug-metabolizing enzymes. Drug Metab Dispos 39: 874-881.
11. Ghose R, White D, Guo T, Vallejo J, and Karpen SJ (2008) Regulation of hepatic drug-metabolizing enzyme genes by Toll-like receptor 4 signaling is independent of Toll-interleukin 1 receptor domain-containing adaptor protein. Drug Metab Dispos 36:95-101.
12. Ghose R, Zimmerman TL, Thevananther S, and Karpen SJ (2004) Endotoxin leads to rapid subcellular re-localization of hepatic RXRalpha: a novel mechanism for reduced hepatic gene expression in inflammation. Nucl Recept 2:4.
13. Hartmann G, Kim H, and Piquette-Miller M (2001) Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmacol 1: 189-199. (Pubitemid 32183718)
14. Hyzy J, Sciotti V, Albini B, and Stinson M (1992) Deposition of circulating streptococcal lip-oteichoic acid in mouse tissues. Microb Pathog 13:123-132.
15. Ishii KJ and Akira S (2004) Toll-like receptors and sepsis. Curr Infect Dis Rep 6:361-366. (Pubitemid 39467915)
16. Kakizaki S, Yamazaki Y, Takizawa D, and Negishi M (2008) New insights on the xenobiotic-sensing nuclear receptors in liver diseases-CAR and PXR-. Curr Drug Metab 9: 614-621.
17. Li D, Zimmerman TL, Thevananther S, Lee HY, Kurie JM, and Karpen SJ (2002) Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-de-pendent. J Biol Chem 277:31416-31422. (Pubitemid 34968941)
18. Liu S, Gallo DJ, Green AM, Williams DL, Gong X, Shapiro RA, Gambotto AA, Humphris EL, Vodovotz Y, and Billiar TR (2002) Role of Toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 70:3433-3442. (Pubitemid 34665980)
19. Mangelsdorf DJ and Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83: 841-850. (Pubitemid 26006526)
20. Matsumura T, Degawa T, Takii T, Hayashi H, Okamoto T, Inoue J, and Onozaki K (2003) TRAF6-NF-kappaB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes. Immunology 109:127-136. (Pubitemid 36577983)
21. Muntané-Relat J, Ourlin JC, Domergue J, and Maurel P (1995) Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 22:1143-1153.
22. Ray A, Chatterjee NS, Bhattacharya SK, and Biswas T (2003) Porin of Shigella dysenteriae enhances mRNA levels for Toll-like receptor 2 and MyD88, up-regulates CD80 of murine macrophage, and induces the release of interleukin-12. FEMS Immunol Med Microbiol 39:213-219. (Pubitemid 37461000)
23. Renton KW (2004) Cytochrome P450 regulation and drug biotransformation during inflammation and infection. Curr Drug Metab 5:235-243. (Pubitemid 38735778)
24. Renton KW and Nicholson TE (2000) Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain. J Pharmacol Exp Ther 294:524-530. (Pubitemid 30490825)
25. Richardson TA and Morgan ET (2005) Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice. J Pharmacol Exp Ther 314:703-709. (Pubitemid 41043852)
26. Schwabe RF, Seki E, and Brenner DA (2006) Toll-like receptor signaling in the liver. Gastro-enterology 130:1886-1900. (Pubitemid 43668871)
27. Sewer MB, Koop DR, and Morgan ET (1997) Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression. J Pharmacol Exp Ther 280:1445-1454. (Pubitemid 27166743)
28. Shen G and Kong AN (2009) Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. Biopharm Drug Dispos 30:345-355.
29. Takeda K and Akira S (2001) Regulation of innate immune responses by Toll-like receptors. Jpn J Infect Dis 54:209-219. (Pubitemid 34285466)
30. Teng S and Piquette-Miller M (2005) The involvement of the pregnane X receptor in hepatic gene regulation during inflammation in mice. J Pharmacol Exp Ther 312:841-848. (Pubitemid 40189587)
31. Tien ES and Negishi M (2006) Nuclear receptors CAR and PXR in the regulation of hepatic metabolism. Xenobiotica 36:1152-1163. (Pubitemid 44844116)
32. Wei P, Zhang J, Egan-Hafley M, Liang S, and Moore DD (2000) The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407:920-923.
33. Zhang J, Huang W, Chua SS, Wei P, and Moore DD (2002) Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR. Science 298:422-424. (Pubitemid 35176352)
34. Zordoky BN and El-Kadi AO (2009) Role of NF-kappaB in the regulation of cytochrome P450 enzymes. Curr Drug Metab 10:164-178.